Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial
2019 ◽
Vol 176
(9)
◽
pp. 1251-1267
◽
2005 ◽
Vol 128
(4)
◽
pp. 160S
◽
2019 ◽
2020 ◽
Vol 201
(6)
◽
pp. 707-717
◽